Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Novel Immunotherapy Targeting IGF1R/IR in TNBC
V FOUNDATION FOR CANCER RESEARCH
3/15/22 → 4/21/24
Project: Research project
-
A Global Phase 2 Study to Evaluate the Efficacy andSafety of ARX788 for Selected HER2-mutated orHER2-amplified/over-expressed Solid Tumors
3/4/22 → 3/31/27
Project: Research project
-
A multi-centre, double-blind, placebo-controlled, randomised phase II trial to compare efficacy of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in post-menopausal women with HR+ / HER2- metastatic breast can
Boehringer-Ingelheim Pharmaceuticals
8/30/18 → 8/30/23
Project: Research project
-
-
Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast cancer: the I-SPY SURMOUNT study
Magbanua, M. J. M., van ‘t Veer, L., Clark, A. S., Chien, A. J., Boughey, J. C., Han, H. S., Wallace, A., Beckwith, H., Liu, M. C., Yau, C., Wileyto, E. P., Ordonez, A., Solanki, T. I., Hsiao, F., Lee, J. C., Basu, A., Brown Swigart, L., Perlmutter, J., Delson, A. L., Bayne, L., & 7 others, Apr 2023, In: Breast Cancer Research and Treatment. 198, 2, p. 383-390 8 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients
I-SPY 2 Trial Consortium, Jan 2022, In: The Lancet Oncology. 23, 1, p. 149-160 12 p.Research output: Contribution to journal › Article › peer-review
Open Access71 Scopus citations -
Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer
Lang, J. E., Forero-Torres, A., Yee, D., Yau, C., Wolf, D., Park, J., Parker, B. A., Chien, A. J., Wallace, A. M., Murthy, R., Albain, K. S., Ellis, E. D., Beckwith, H., Haley, B. B., Elias, A. D., Boughey, J. C., Yung, R. L., Isaacs, C., Clark, A. S., Han, H. S., & 29 others, Dec 2022, In: npj Breast Cancer. 8, 1, 128.Research output: Contribution to journal › Article › peer-review
Open Access -
The 70-gene signature test as a prognostic and predictive biomarker in patients with invasive lobular breast cancer
Jenkins, J. A., Marmor, S., Hui, J., Beckwith, H., Blaes, A. H., Potter, D. A. & Tuttle, T. M., Jan 2022, In: Breast Cancer Research and Treatment. 191, 2, p. 401-407 7 p.Research output: Contribution to journal › Article › peer-review
8 Scopus citations -
Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial
Pusztai, L., Yau, C., Wolf, D. M., Han, H. S., Du, L., Wallace, A. M., String-Reasor, E., Boughey, J. C., Chien, A. J., Elias, A. D., Beckwith, H., Nanda, R., Albain, K. S., Clark, A. S., Kemmer, K., Kalinsky, K., Isaacs, C., Thomas, A., Shatsky, R., Helsten, T. L., & 25 others, Jul 12 2021, In: Cancer Cell. 39, 7, p. 989-998.e5Research output: Contribution to journal › Article › peer-review
70 Scopus citations
Datasets
-
COVID-19 Concerns among Physicians who treat cancer survey in the United States, Cross-sectional study March/April 2020
Vogel, R., Thomaier, L., Lou, E., Teoh, D. G., Jewett, P. I., Beckwith, H. C., Parsons, H. M., Yuan, J., Blaes, A. H. & Hui, J., Data Repository for the University of Minnesota, 2020
DOI: 10.13020/bmsy-hb61, http://hdl.handle.net/11299/216451
Dataset